Blog - Page 2982 of 5461

MondayMay 14, 2012 10:28 am

American Standard Energy Corp. (ASEN) Reports Financial Results for First Quarter of 2012

American Standard Energy reported a sharp year-over-year increase in oil and gas revenues in the first quarter of 2012. The company also confirmed progress on the exploration and development of onshore oil and gas assets. American Standard Energy reported oil and gas sales of $5 million in the quarter ending March 31, 2012, up 109% from the $2.4 million recorded in the corresponding quarter of 2011. The company said that the increase was due to many factors, including higher production and higher realized prices for crude oil. American Standard Energy reported production of 68,137 barrels of oil equivalent (BOE) in…

MondayMay 14, 2012 10:17 am

International Stem Cell Corp. (ISCO) Video Chart for Monday, May 14, 2012

ISCO has formed a triple bottom pattern with support at 40 cents. There is more support down at 34 cents, but the 40 cent mark has produced two bounces in excess of 50 percent (to $0.68 and $0.65) in the last five months. Technical traders will be watching closely for the pattern to repeat. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts: International Stem Cell Corp. Message Board

MondayMay 14, 2012 8:57 am

Cover-All Technologies, Inc. (COVR) NexGen Business Intelligence Solution Featured in Recent Novarica Report

Cover-All Technologies, a Delaware corporation and leading developer of sophisticated software solutions for the property and casualty insurance industry, announced its business intelligence (BI) solution, NexGen Business Intelligence, has been included in a Novarica report profiling insurance BI solutions. Novarica is a research and advisory firm focused on insurance technology strategy. The report, “Business Intelligence Solutions for U.S. Insurers 2012 (Q1),” profiles 19 vendors that currently offer BI solutions. The report describes the growing importance of BI and key areas of use by property/casualty insurance companies. According to Martina Conlon, principal for Novarica’s insurance team and author of the report,…

MondayMay 14, 2012 8:50 am

Quasar Aerospace Industries, Inc. (QASP) Announces Major Reduction in Authorized Shares

Quasar Aerospace Industries just announced that after a meeting of the majority of shareholders and the Board of Directors, the company has reduced the total number of shares authorized to four hundred and seventy-five million (475,000,000). According to the press release issued this morning, Quasar Aerospace felt that the share reduction was prudent at this time. The company stated that it will continue to look to align its share structure and capitalization more appropriately; including the conversion terms of the preferred shares. Quasar Aerospace also reminded the investment company of its announced conference call scheduled for Wednesday May 16, 2012,…

FridayMay 11, 2012 4:51 pm

Quasar Aerospace Industries, Inc. (QASP) is “One to Watch”

Quasar Aerospace Industries is an integrated aviation/aerospace corporation focused on executing an innovative and highly synergistic business strategy to develop competitive aircraft and train aircraft pilots. By combining several businesses in the aviation/aerospace industry with an integrated and self-supporting network, the company will be able to operate in a more complex environment and achieve greater success. Rather than forcing acquired business to conform to a master corporate plan, Quasar allows these entities to retain their operational independence and unique corporate cultures. In doing so, the resources, talents, insight, experience, and market potential of each will be supported and enhanced in…

FridayMay 11, 2012 3:54 pm

Cardium Therapeutics, Inc. (CXM) Growing Footprint in Health Sciences and Regenerative Medicine Space

Cardium Therapeutics has built a name for itself by capturing innovative biomedical technologies that emerge in the health sciences and regenerative medicine space, while simultaneously developing its own technology portfolio. By focusing on underserved demand and products/business opportunities with a clear path to monetization, CXM has been able to create a lightweight approach that harnesses all of the external partner, market, and technology strengths, while avoiding the cost structure pitfalls that plague many other operators in the same sector. The envelope of medical business opportunities CXM has assembled to date includes the in-house MedPodium® Health Sciences healthy lifestyle product platform,…

FridayMay 11, 2012 3:29 pm

CytoSorbents Corp. (CTSO) CEO Named as Finalist for Ernst & Young Entrepreneur of the Year 2012

CytoSorbents, a critical care-focused company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses, today announced its CEO, Dr. Phillip Chan, was named as a finalist in the Ernst & Young Entrepreneur Of The Year® 2012 program, which recognizes entrepreneurs with demonstrated success in areas such as innovation, financial performance, and personal commitment. Dr. Chan was selected by an independent judging panel comprised of previous winners, CEOs, private capital investors, and other regional business leaders. Since his appointment as CytoSorbents CEO and president in 2009, Dr. Chan has taken initiatives to build the company…

FridayMay 11, 2012 3:24 pm

European Medicines Agency Awards Arno Therapeutics, Inc. (ARNI) AR-42 Orphan Drug Designation

Arno Therapeutics, a clinical-stage company focused on developing products for the treatment of cancer, today announced that its investigational compound AR-42 has been granted orphan-drug designation by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products for the treatment of neurofibromatosis type 2 (NF2), a rare genetic disorder characterized by the growth of noncancerous tumors in the brain and spinal cord, juvenile cataracts, and neurofibromas of the skin. The EMA grants orphan-drug designation for medicines designed to treat life-threatening or debilitating conditions affecting no more than five in 10,000 people, and allows the developer to obtain inspection-fee reductions, protocol…

FridayMay 11, 2012 12:49 pm

American Energy Development Corp. (AEDC) Gives Drilling Update on Project in Michigan

American Energy Development is an independent oil and gas company seeking to expand through the development of acreage in established oil and gas basins. The company's current focus is on development of acreage in the Niagaran oil reefs in Michigan and in underexplored onshore basins in the United Kingdom. The Niagaran Reef is of particular interest to the company. Historical records of the Niagaran reef production in Michigan confirm more than 4,200 wells have been drilled targeting reef formations. Much of the drilling in the region has been conducted by major players in the energy industry, including Royal Dutch Shell,…

FridayMay 11, 2012 12:39 pm

SilverSun Technologies, Inc. (SSNT) and the Internal Turnaround

When one thinks of company turnarounds, it’s normal to imagine outside investors bringing in their own people, restructuring everything, perhaps chopping off various company operations, or even pointing the company to a brand new market. More common, however, is the internal turnaround, sometimes led by a new CEO, but often simply initiated by a transition in thinking within the existing executive team. Some attempts are successful, others are not. Indeed it is said that the quality of a company is best measured by how they respond to difficult times. Such is the case with SilverSun Technologies, a nationwide small business…

Site Search

Company Search